Free tool
FAERS Monitor: Mysoline
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 009170 or its brand name (Mysoline, Primidone). Reports on generic versions are filed under their own applications.
Reports
10,264
Serious
6,711
65% of reports
Hospitalization
3,199
Death reported
884
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective845
- fall673
- fatigue650
- tremor591
- off label use509
- dizziness508
- diarrhoea506
- nausea479
- drug interaction410
- headache407
- somnolence392
- dyspnoea368
- asthenia365
- weight decreased338
- pain331
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 173 |
| 2005 | 195 |
| 2006 | 175 |
| 2007 | 157 |
| 2008 | 184 |
| 2009 | 195 |
| 2010 | 277 |
| 2011 | 300 |
| 2012 | 345 |
| 2013 | 352 |
| 2014 | 391 |
| 2015 | 676 |
| 2016 | 743 |
| 2017 | 666 |
| 2018 | 673 |
| 2019 | 684 |
| 2020 | 692 |
| 2021 | 636 |
| 2022 | 562 |
| 2023 | 591 |
| 2024 | 570 |
| 2025 | 580 |
| 2026 | 446 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| tremorSignal | 591 | 7.3 | 6.8 | 3,232 |
| drug interactionSignal | 410 | 5.3 | 4.8 | 1,436 |
| fallSignal | 673 | 4.2 | 3.9 | 1,629 |
| somnolenceSignal | 392 | 4.0 | 3.6 | 884 |
| weight decreasedSignal | 338 | 2.5 | 2.2 | 301 |
| dizzinessSignal | 508 | 2.1 | 1.9 | 294 |
| asthenia | 365 | 2.0 | 1.8 | 182 |
| fatigue | 650 | 1.7 | 1.6 | 199 |
| diarrhoea | 506 | 1.6 | 1.5 | 119 |
| dyspnoea | 368 | 1.3 | 1.2 | 31 |
| headache | 407 | 1.3 | 1.2 | 34 |
| drug ineffective | 845 | 1.3 | 1.2 | 67 |
| nausea | 479 | 1.2 | 1.1 | 23 |
| off label use | 509 | 1.2 | 1.1 | 16 |
| pain | 331 | 1.1 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.